Stay updated on Pembrolizumab in CAR T Failure Lymphomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page now shows an updated site revision identifier (moving from v3.5.2 to v3.5.3), indicating a platform/version update without altering the study record content.
    Difference
    0.1%
    Check dated 2026-04-24T06:39:43.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:55:09.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    41 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T05:32:49.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T00:34:14.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The page adds Revision: v3.4.2, and removes a government funding lapse notice and the older Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T14:09:17.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    A government funding lapse notice now appears on the page, stating that information may not be up to date. The site version was updated to Revision: v3.4.1, replacing v3.4.0.
    Difference
    0.5%
    Check dated 2026-02-04T10:18:19.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in CAR T Failure Lymphomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page.